{"id":242050,"date":"2012-09-19T03:11:10","date_gmt":"2012-09-19T03:11:10","guid":{"rendered":"http:\/\/www.eugenesis.com\/purple-corn-compound-may-aid-in-developing-future-treatments-for-type-2-diabetes-kidney-disease\/"},"modified":"2012-09-19T03:11:10","modified_gmt":"2012-09-19T03:11:10","slug":"purple-corn-compound-may-aid-in-developing-future-treatments-for-type-2-diabetes-kidney-disease","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biochemistry\/purple-corn-compound-may-aid-in-developing-future-treatments-for-type-2-diabetes-kidney-disease.php","title":{"rendered":"Purple corn compound may aid in developing future treatments for Type 2 diabetes, kidney disease"},"content":{"rendered":"<p><p>Public  release date: 18-Sep-2012  [ |   E-mail   |  Share    ]  <\/p>\n<p>    Contact: Donna Krupa    <a href=\"mailto:dkrupa@the-aps.org\">dkrupa@the-aps.org<\/a>    American    Physiological Society<\/p>\n<p>    BETHESDA, Md. (Sept. 18, 2012)Diabetic nephropathy is one of    the most serious complications related to diabetes, often    leading to end-stage kidney disease. Purple corn grown in Peru    and Chile is a relative of blue corn, which is readily    available in the U.S. The maize is rich in anthocyanins (also    known as flavonoids), which are reported to have anti-diabetic    properties. Scientists from the Department of Food and    Nutrition and Department of Biochemistry at Hallym University    in Korea investigated the cellular and molecular activity of    purple corn anthocyanins (PCA) to determine whether and how it    affects the development of diabetic nephropathy (DN). Their    findings suggest that PCA inhibits multiple pathways involved    in the development of DN, which may help in developing    therapies aimed at type 2 diabetes and kidney disease.  <\/p>\n<p>    The study is entitled \"Purple corn anthocyanins inhibit    diabetes-associated glomerular monocyte activation and    macrophage infiltration\" <a href=\"http:\/\/bit.ly\/SlrkRY\" rel=\"nofollow\">http:\/\/bit.ly\/SlrkRY<\/a>. It appears in    the online edition of the American Journal of Physiology     Renal Physiology, published by the American Physiological    Society (APS; <a href=\"http:\/\/www.the-aps.org\" rel=\"nofollow\">http:\/\/www.the-aps.org<\/a>).  <\/p>\n<p>    Methodology  <\/p>\n<p>    Researcher Min-Kyung Kang and colleagues performed a two-part    study, an in vitro experiment investigating the effects of PCA    on human endothelial cells cultured under hyperglycemic kidney    conditions and an in vivo study that investigated the effects    of PCA on kidney tissue in diabetic mice. In the in vitro    experiment, cultured cells were exposed to 1-20 g\/ml of PCA    for six hours (control cells were not exposed), then assessed    for level of monocyte-endothelial cell adhesion, a major factor    in the development of diabetic glomerulosclerosis. In the in    vivo experiment, diabetic and control mice were dosed with PCA    for eight weeks, then changes in kidney tissue were assessed    and immunohistological analyses were performed. Kidney tissue    was further analyzed for levels of inflammatory chemokines,    which are key components in DN.  <\/p>\n<p>    Results  <\/p>\n<p>    Researchers found that in human endothelial cells cultured in    hyperglycemic kidney conditions, induction of endothelial cell    adhesion molecules decreased in a dose-dependent manner with    PCA exposure, meaning that the PCA likely interfered with    cell-cell adhesion in glomeruli. PCA also appeared to interfere    with leukocyte recruitment and adhesion to glomerular    endothelial cells. In diabetic mice, PCA exposure slowed    mesangial expansion and interrupted the cellular signaling    pathway that may instigate glomerular adhesion and infiltration    of inflammatory cells responsible for diabetic    glomerulosclerosis. Finally, PCA inhibited levels of macrophage    inflammatory protein-2 and monocyte chemotactic protein-1 in    kidney tissue, demonstrating that it may inhibit macrophage    infiltration, which is closely related to renal inflammation.  <\/p>\n<p>    Importance of the Findings  <\/p>\n<p>    The research suggests that anthocyanins may be the main    biofunctional compound in purple corn and could protect against    mesangial activation of monocytes and infiltration of    macrophages in glomerulithe two major contributors to DN. The    research further suggests that renoprotection by PCA against    mesangial activation may be specific therapies targeting    diabetes-associated diabetic glomerulosclerosis and renal    inflammation. Finally, PCA supplementation may be an important    strategy in preventing renal vascular disease in type 2    diabetes.  <\/p>\n<\/p>\n<p>Read the original here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2012-09\/aps-pcc091812.php\" title=\"Purple corn compound may aid in developing future treatments for Type 2 diabetes, kidney disease\">Purple corn compound may aid in developing future treatments for Type 2 diabetes, kidney disease<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Public release date: 18-Sep-2012 [ | E-mail | Share ] Contact: Donna Krupa <a href=\"mailto:dkrupa@the-aps.org\">dkrupa@the-aps.org<\/a> American Physiological Society BETHESDA, Md. (Sept.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biochemistry\/purple-corn-compound-may-aid-in-developing-future-treatments-for-type-2-diabetes-kidney-disease.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577469],"tags":[],"class_list":["post-242050","post","type-post","status-publish","format-standard","hentry","category-biochemistry"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/242050"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=242050"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/242050\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=242050"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=242050"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=242050"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}